Ocular Therapeutix Inc banner

Ocular Therapeutix Inc
NASDAQ:OCUL

Watchlist Manager
Ocular Therapeutix Inc Logo
Ocular Therapeutix Inc
NASDAQ:OCUL
Watchlist
Price: 8.09 USD -2.88%
Market Cap: $1.8B

Wall Street
Price Targets

OCUL Price Targets Summary
Ocular Therapeutix Inc

Wall Street analysts forecast OCUL stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for OCUL is 25.5 USD with a low forecast of 18.18 USD and a high forecast of 35.7 USD.

Lowest
Price Target
18.18 USD
125% Upside
Average
Price Target
25.5 USD
215% Upside
Highest
Price Target
35.7 USD
341% Upside
Ocular Therapeutix Inc Competitors:
Price Targets

Revenue
Forecast

N/A
Past Growth
80% / Year
Estimated Growth
Estimates Accuracy
-7%
Average Miss
N/A
Past Growth
80% / Year
Estimated Growth
Estimates Accuracy
-7%
Average Miss

The compound annual growth rate of Ocular Therapeutix Inc's revenue for the next 3 years is 80%.

Operating Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-1%
Average Miss
N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-1%
Average Miss

Net Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-80%
Average Miss
N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-80%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is OCUL's stock price target?
Price Target
25.5 USD

According to Wall Street analysts, the average 1-year price target for OCUL is 25.5 USD with a low forecast of 18.18 USD and a high forecast of 35.7 USD.

What is Ocular Therapeutix Inc's Revenue forecast?
Projected CAGR
80%

The compound annual growth rate of Ocular Therapeutix Inc's revenue for the next 3 years is 80%.

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett